🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for NAFLD - Nonalcoholic Fatty Liver Disease

Effectiveness of Bariatric Surgery for NAFLD/NASH NCT04366999n/a1 site📍 Beijing Beijing Friendship Hospital · Tests: SG, RYGB, OAGB Digital Early Warning System for Acute Lung Injury in Liver Surgery NCT07070362n/a4 sites📍 Beijing📍 Beijing📍 Chongqing Beijing Tsinghua Chang Gung Hospital Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease NCT05439226NA3 sites📍 Yichang📍 Changsha📍 Changsha State Key Laboratory of Subhealth Intervention Technology · Tests: CMNT diet Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) NCT04634643n/a1 site📍 New Haven Yale University · Tests: Usual diet and physical activity Clinical Course and Biomarkers Associated With Nonalcoholic Fatty Liver Disease (NAFLD) in Chinese Patients With Obesity NCT07662356n/a1 site📍 Hong Kong Chinese University of Hong Kong · Tests: Case Group The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) NCT07093346NA3 sites📍 Nottingham📍 Nottingham📍 Nottingham University of Nottingham · Tests: Pectin, Cocoa Powder, Magnetic Resonance Imaging with Contrast The European NAFLD Registry NCT04442334n/a37 sites📍 Antwerp📍 Helsinki📍 Angers Newcastle University The COherence of Scatter Identification and Exclusion Algorithm Study NCT06975579n/a1 site📍 London Institute of Cancer Research, United Kingdom · Tests: Ultrasound image processing Prevention of NAFLD and CVD Through Lifestyle Intervention NCT05618626NA1 site📍 Molina Pontificia Universidad Catolica de Chile · Tests: Physical exercise and dietary intervention for NAFLD To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease NCT07149571n/a1 site📍 Wuhan Tongji Hospital Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis NCT03572465n/a1 site📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Acoustic radiation force impulse (ARFI), magnetic resonance elastography (MRE) Evaluation of Risk of hEpatocellular Carcinoma NCT06523179NA1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: quantify the impact of genetic risk factors Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly NCT07068191NA1 site📍 Tyumen Phenomen Pharma · Tests: Dietary supplement "Gepaktiv", UDCA (Ursodeoxycholic acid), Ademetionine Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD NCT06449833Phase 41 site📍 Guangzhou Zhujiang Hospital · Tests: Henagliflozein and Metformin, Linagliptin and Metformin A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China NCT04573283n/a1 site📍 Guangzhou Nanfang Hospital, Southern Medical University Prevalence of NAFLD in T1DM Patients NCT06445361NA1 site📍 Genk Ziekenhuis Oost-Limburg · Tests: FibroScan Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal NCT06707129n/a1 site📍 Beijing Beijing Municipal Administration of Hospitals · Tests: life-style Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis NCT05720663n/a2 sites📍 Rochester📍 Richmond Virginia Commonwealth University · Tests: Standard of care Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases NCT07248371n/a1 site📍 Taoyuan Chang Gung Memorial Hospital · Tests: No intervention Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program NCT06115876n/a1 site📍 Kuwait City Dasman Diabetes Institute Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial NCT07193927Phase 21 site📍 Girona AB Biotics, SA · Tests: Lactiplantibacillus plantarum Probiotic Mixture, Placebo comparator containing maltodextrin Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis NCT07265297Phase 31 site📍 Taipei National Taiwan University Hospital · Tests: Hydrochloroquine, Placebo Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD NCT05766449n/a1 site📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease NCT07051863n/a1 site📍 Lugano Fondazione Epatocentro Ticino A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) NCT07165028Phase 3563 sites📍 Tuscaloosa📍 Chandler📍 Gilbert Eli Lilly and Company · Tests: Tirzepatide, Retatrutide, Placebo A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients NCT03472157NA1 site📍 Lille University Hospital, Lille · Tests: Lifestyle therapy, Bariatric surgery Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans NCT05526144Phase 21 site📍 Columbia VA Office of Research and Development · Tests: Synthroid, Placebo Digoxin In NASH (CODIN) NCT06588699Phase 22 sites📍 New Haven📍 New Haven Yale University · Tests: Digoxin, Placebo Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease NCT03635541n/a1 site📍 Beijing Beijing Friendship Hospital · Tests: observational group of NAFLD Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance NCT05165706NA1 site📍 Stanford Stanford University · Tests: Dietary Intervention Mediterranean Low Carbohydrate Diet, Dietary Intervention Standard Low Carbohydrate Diet, Dietary …
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy